The Trump administration will end a program that has helped limit premium increases for stand-alone Medicare prescription drug plans, potentially leaving some beneficiaries with higher monthly costs in 2027.
Aliss Higham is a Newsweek reporter based in Glasgow, Scotland. Her reporting focuses on Social Security, government benefits, and personal finance, while also covering themes related to politics, public policy, and consumer health. Aliss has been featured in various publications including Magzter, The Daily Express, and Yahoo Finance, among others.










